Sight Sciences (SGHT) EVP Brenton sells 2,869 shares for RSU tax obligations

Rhea-AI Filing Summary

Sight Sciences EVP Taylor Brenton sold 2,869 shares of Common Stock at a weighted average price of $3.70 per share. According to the disclosure, these shares were sold solely to cover tax liabilities arising from the vesting of restricted stock units, rather than as a discretionary portfolio move.

After this tax-related sale, Brenton holds 267,807 shares, including 31,631 shares of Common Stock and 236,176 additional shares that are scheduled to be received upon future vesting and settlement of RSUs. This indicates the transaction affected only a small portion of his overall equity exposure to the company.

Insights

Insider trading and governance analyst

Small, tax-driven insider sale with large remaining stake.

The filing shows EVP of Operations & R&D Taylor Brenton executed an open-market sale of 2,869 shares of Sight Sciences at a weighted average of $3.70 per share. Footnotes state the sale was specifically to cover tax obligations from restricted stock unit vesting.

Because the sale is tied to tax withholding rather than a discretionary decision, its informational value as a signal of insider sentiment is limited. After the sale, Brenton still holds 267,807 shares, including 236,176 shares issuable upon future RSU vesting, suggesting his remaining equity exposure is substantial relative to the shares sold.

From an investor perspective, this appears to be a routine compensation-related transaction. It updates the share overhang from RSUs and confirms continuing alignment between the executive’s interests and shareholders through a sizable ongoing ownership position, based on the holdings disclosed as of the transaction date.

Insider Trade Summary 10b5-1

Net Seller: 2,869 shares ($10,615)

Net Sell 1 txn

Insider Taylor Brenton

Role EVP, Operations & R&D

Sold 2,869 shs ($11K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,869	$3.70	$11K

Holdings After Transaction: Common Stock — 267,807 shares (Direct)

Footnotes (1)

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs"). Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes (i) 31,631 shares of Common Stock, and (ii) 236,176 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

Key Figures

Shares sold: 2,869 shares Weighted average sale price: $3.70 per share Post-transaction holdings: 267,807 shares +3 more

6 metrics

Shares sold 2,869 shares Open-market sale on 2026-04-01

Weighted average sale price $3.70 per share Common Stock sale to cover taxes

Post-transaction holdings 267,807 shares Total holdings after sale

Current Common Stock held 31,631 shares Portion of total holdings already issued

Unvested RSU-linked shares 236,176 shares To be acquired upon future RSU vesting and settlement

Sale price range $3.63–$3.85 per share Range of individual trade prices on sale date

Key Terms

restricted stock units, weighted average price, vesting and settlement, open-market sale, +1 more

5 terms

restricted stock units financial

"in connection with the vesting of restricted stock units ("RSUs")."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average price financial

"Reflects the weighted average price at which the shares of Common Stock were sold."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting and settlement financial

"shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested."

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

tax liability financial

"sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Taylor Brenton

(Last) (First) (Middle)

C/O SIGHT SCIENCES, INC.

4040 CAMPBELL AVE., SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Operations & R&D

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		S		2,869(1)	D	$3.7(2)	267,807(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

2. Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Includes (i) 31,631 shares of Common Stock, and (ii) 236,176 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.

	/s/Jeremy Hayden, Attorney-in-Fact for Brenton Taylor	04/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Sight Sciences (SGHT) report for Taylor Brenton?

Sight Sciences reported that EVP Taylor Brenton sold 2,869 shares of Common Stock at a weighted average price of $3.70 per share. The filing explains this sale was made to cover his tax liability arising from the vesting of restricted stock units.

Was Taylor Brenton’s Sight Sciences (SGHT) share sale a tax-related transaction?

Yes. The disclosure states the 2,869 Sight Sciences shares were sold specifically to cover the reporting person’s tax liability linked to vesting RSUs. This indicates the sale was driven by compensation-related taxes rather than a discretionary reduction of his investment position.

How many Sight Sciences (SGHT) shares does Taylor Brenton hold after the transaction?

Following the sale, Taylor Brenton is reported to hold 267,807 shares in total. This includes 31,631 shares of Common Stock already held and 236,176 additional shares that are expected to be received upon the future vesting and settlement of restricted stock units.

What price range did Taylor Brenton’s Sight Sciences (SGHT) shares sell for?

The filing shows a weighted average sale price of $3.70 per share, with individual trades executed between $3.63 and $3.85. The reporting person has undertaken to provide detailed breakdowns of the number of shares sold at each separate price upon request.

Does the Sight Sciences (SGHT) Form 4 suggest Taylor Brenton exercised stock options?

No option exercises are reported in this Form 4. The transaction involves a sale of Common Stock to cover taxes from restricted stock unit vesting, and the filing does not list any derivative securities or option exercises for the reported date.

How significant is Taylor Brenton’s Sight Sciences (SGHT) share sale compared with his total holdings?

The reported sale of 2,869 shares is small relative to Brenton’s 267,807 total shares reported after the transaction. Given the stated tax-coverage purpose, the filing portrays this as a limited, routine adjustment rather than a major change in his equity exposure.